Anti-Müllerian hormone and ovarian reserve: update on assessing ovarian function

LME Moolhuijsen, JA Visser - The Journal of Clinical …, 2020 - academic.oup.com
Context Anti-müllerian hormone (AMH) is produced by granulosa cells of small, growing
follicles in the ovary. Serum AMH levels strongly correlate with the number of growing …

[HTML][HTML] Forty years of IVF

C Niederberger, A Pellicer, J Cohen, DK Gardner… - Fertility and sterility, 2018 - Elsevier
This monograph, written by the pioneers of IVF and reproductive medicine, celebrates the
history, achievements, and medical advancements made over the last 40 years in this …

ESHRE guideline: ovarian stimulation for IVF/ICSI

ESHRE Guideline Group on Ovarian … - Human …, 2020 - academic.oup.com
STUDY QUESTION What is the recommended management of ovarian stimulation, based
on the best available evidence in the literature? SUMMARY ANSWER The guideline …

Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications

SL Broer, FJM Broekmans, JSE Laven… - Human reproduction …, 2014 - academic.oup.com
BACKGROUND In women, anti-Müllerian hormone (AMH) is exclusively produced by
granulosa cells of ovarian follicles during the early stages of follicle development. After an …

[HTML][HTML] Testing and interpreting measures of ovarian reserve: a committee opinion

A Penzias, R Azziz, K Bendikson, T Falcone… - Fertility and sterility, 2020 - Elsevier
Ovarian reserve is defined as the number of oocytes remaining in the ovary, or oocyte
quantity (oocyte number). Markers of ovarian reserve include hormone levels and …

[HTML][HTML] ESHRE guideline: ovarian stimulation for IVF/ICSI

TEGG on Ovarian, E Bosch, S Broer… - Human reproduction …, 2020 - ncbi.nlm.nih.gov
STUDY DESIGN, SIZE, DURATION: The guideline was developed according to the
structured methodology for development of ESHRE guidelines. After formulation of key …

Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response

S Iliodromiti, RA Anderson… - Human reproduction …, 2015 - academic.oup.com
BACKGROUND Stratified (individualized) medicine has been recognized as a key priority
for policy makers and healthcare providers. The main principle of individualized care …

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)

SF Lensen, J Wilkinson, JA Leijdekkers… - Cochrane Database …, 2018 - cochranelibrary.com
Background During a cycle of in vitro fertilisation plus intracytoplasmic sperm injection
(IVF/ICSI), women receive daily doses of gonadotropin follicle‐stimulating hormone (FSH) to …

Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention

CO Nastri, DM Teixeira, RM Moroni… - … in Obstetrics & …, 2015 - Wiley Online Library
Objective To identify, appraise and summarize the current evidence regarding the
pathophysiology, staging, prediction and prevention of ovarian hyperstimulation syndrome …

[HTML][HTML] Management of poor responders in IVF: is there anything new?

F Ubaldi, A Vaiarelli, R D'Anna, L Rienzi - BioMed research …, 2014 - hindawi.com
Despite the fact that in the last two decades an enormous number of papers on the topic of
poor ovarian response have been published in the literature, so far it has been impossible to …